Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 624 clinical trials in Dordrecht, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on Dapagliflozin for Kidney Protection in Heart Transplant Patients
The NetherlandsStudy of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma
The NetherlandsStudy of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis
The NetherlandsStudy of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia
The NetherlandsStudy on Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Liver, Colon, Pancreatic, Bile Duct, Gallbladder, Endometrial, or Esophageal Cancer
The NetherlandsStudy of Favezelimab Combined with Pembrolizumab (MK-4280A) for Patients with Selected Solid Tumors
The NetherlandsStudy of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
The NetherlandsStudy on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis
The NetherlandsStudy of Avutometinib, Sotorasib, and Defactinib for Patients with KRAS G12C Mutant Non-Small Cell Lung Cancer
The NetherlandsStudy of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema
The NetherlandsStudy of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer
The NetherlandsStudy on Switching HIV Treatment to Dolutegravir/Lamivudine in Patients Aged 50+ with Virologic Suppression
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Acute Myeloid Leukemia (AML) and various forms of Multiple Myeloma, evaluating novel drug combinations and treatment approaches for patients ineligible for intensive chemotherapy.
Studies aim to improve survival rates and treatment outcomes in previously untreated patients.
Research centered on atherosclerotic cardiovascular disease and deep vein thrombosis, investigating new therapeutic approaches and preventive strategies.
Clinical trials focus on improving patient outcomes through innovative treatments and prevention strategies.
Studies examining treatments for thyroid conditions and hormonal disorders, comparing conventional and innovative therapeutic approaches.
Research aims to enhance treatment efficacy while minimizing side effects.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
